- Changes in Automated Mammographic Breast Density Can Predict Pathological Response After Neoadjuvant Chemotherapy in Breast Cancer
-
Ahn JH, Go J, Lee SJ, Kim JY, Park HS, Kim SI, Park BW, Park VY, Yoon JH, Kim MJ, Park S
- KMID: 2541958
- Korean J Radiol.
- 2023 May;24(5):384-394.
- doi: 10.3348/kjr.2022.0629
Objective: Mammographic density is an independent risk factor for breast cancer that can change after neoadjuvant chemotherapy (NCT). This study aimed to evaluate percent changes in volumetric breast density (ΔVbd%)... -
- CITED
-
- Close
- SHARE
-
- Close
- Predicting Pathological Complete Response in Breast Cancer After Two Cycles of Neoadjuvant Chemotherapy by Tumor Reduction Rate: A Retrospective Case-Control Study
-
Yao L, Liu X, Wang M, Yu K, Xu S, Qiu P, Lv Z, Zhang X, Xu Y
- KMID: 2541764
- J Breast Cancer.
- 2023 Apr;26(2):136-151.
- doi: 10.4048/jbc.2023.26.e12
Purpose: We aimed to identify effectiveness-associated indicators and evaluate the optimal tumor reduction rate (TRR) after two cycles of neoadjuvant chemotherapy (NAC) in patients with invasive breast cancer. Methods: This retrospective... -
- CITED
-
- Close
- SHARE
-
- Close
- Difference in prognostic impact of lateral pelvic lymph node metastasis between pre- and post-neoadjuvant chemoradiotherapy in rectal cancer patients
-
Lim BL, Park IJ, Kim YI, Kim CW, Lee JL, Yoon YS, Lim SB
- KMID: 2541146
- Ann Surg Treat Res.
- 2023 Apr;104(4):205-213.
- doi: 10.4174/astr.2023.104.4.205
Purpose: The prognostic significance and treatment of lateral pelvic lymph node metastasis (mLPLN) in rectal cancer patients receiving neoadjuvant chemoradiotherapy (nCRT) are not well understood. In this study, we evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of the Role of Axillary Lymph Node Fine-Needle Aspiration Cytology in Early Breast Cancer With or Without Neoadjuvant Chemotherapy
-
Takatsuka D, Yoshimura A, Sawaki M, Hattori M, Kotani H, Kataoka A, Horisawa N, Ozaki Y, Endo Y, Nozawa K, Iwata H
- KMID: 2541762
- J Breast Cancer.
- 2023 Apr;26(2):117-125.
- doi: 10.4048/jbc.2023.26.e13
Purpose: Fine-needle aspiration cytology (FNAC) of axillary lymph nodes (AxLNs) is performed to diagnose nodal metastasis in patients with breast cancer. Although the sensitivity of ultrasound-guided FNAC for identifying AxLN... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Postmastectomy Radiation Therapy on Breast Cancer Patients According to Pathologic Nodal Status after Modern Neoadjuvant Chemotherapy
-
Kim D, Kim JH, Kim IA, Chang JH, Shin KH
- KMID: 2541246
- Cancer Res Treat.
- 2023 Apr;55(2):592-602.
- doi: 10.4143/crt.2022.998
Purpose The utility of postmastectomy radiation therapy (PMRT) for breast cancer patients after neoadjuvant chemotherapy (NAC) is highly controversial. This study evaluated the impact of PMRT according to pathologic nodal... -
- CITED
-
- Close
- SHARE
-
- Close
- Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
-
Kim H, Jeong BC, Hong J, Kwon GY, Kim CK, Park W, Pyo H, Song W, Sung HH, Hong JY, Park SH
- KMID: 2541250
- Cancer Res Treat.
- 2023 Apr;55(2):636-642.
- doi: 10.4143/crt.2022.343
Purpose The activity and safety of neoadjuvant nivolumab plus gemcitabine/cisplatin (N+GC) were tested in patients with muscle-invasive bladder urothelial carcinoma (MIBC). Materials and Methods In a prospective phase II trial, patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Dancing with the Surgeon: Neoadjuvant and Adjuvant Immunotherapies from the Medical Oncologist’s Perspective
-
Park S
- KMID: 2540068
- J Chest Surg.
- 2023 Mar;56(2):67-74.
- doi: 10.5090/jcs.23.009
Perioperative treatment with conventional cytotoxic chemotherapy for resectable nonsmall cell lung cancer (NSCLC) has proven clinical benefits in terms of achieving a higher overall survival (OS) rate. With its success... -
- CITED
-
- Close
- SHARE
-
- Close
- Feasibility of Ultrasound-Guided Localization for Clipped Metastatic Axillary Lymph Nodes After Neoadjuvant Chemotherapy in Breast Cancer Patients: A Pilot Study
-
Kim H, Ko EY, Han BK, Ko ES, Choi JS, Lee JE, Cho SY
- KMID: 2540047
- J Breast Cancer.
- 2023 Feb;26(1):77-85.
- doi: 10.4048/jbc.2023.26.e6
We present our initial experience of ultrasound (US)-guided localization of clipped metastatic axillary lymph nodes (LNs) following neoadjuvant chemotherapy (NAC). We evaluated US visibility and the successful excision rate of... -
- CITED
-
- Close
- SHARE
-
- Close
- Pancreatoduodenectomy following neoadjuvant chemotherapy in duodenal adenocarcinoma
-
Seo D, Park BG, Jung D, Hwang HK, Kim SH, Hong SS, Kang CM
- KMID: 2539522
- Ann Hepatobiliary Pancreat Surg.
- 2023 Feb;27(1):114-119.
- doi: 10.14701/ahbps.22-069
A 51-year-old male patient had four times of massive hematochezia episode three days before arrival. Carbohydrate antigen (CA) 19-9 level was extremely elevated. Computed tomography, magnetic resonance imaging, and positron... -
- CITED
-
- Close
- SHARE
-
- Close
- Neoadjuvant chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: Meta-analysis and trial sequential analysis of randomized controlled trials
-
Hajibandeh S, Hajibandeh S, Intrator C, Hassan K, Sehmbhi M, Shah J, Mazumdar E, Kausar A, Satyadas T
- KMID: 2539511
- Ann Hepatobiliary Pancreat Surg.
- 2023 Feb;27(1):28-39.
- doi: 10.14701/ahbps.22-052
We aimed to compare resection and survival outcomes of neoadjuvant chemoradiotherapy (CRT) and immediate surgery in patients with resectable pancreatic cancer (RPC) or borderline resectable pancreatic cancer (BRPC). In compliance... -
- CITED
-
- Close
- SHARE
-
- Close
- An investigation into tumor regression grade as a parameter for locally advanced rectal cancer and 5-year overall survival rate
-
Laohawiriyakamol S, Chaochankit W, Wanichsuwan W, Kanjanapradit K, Laohawiriyakamol T
- KMID: 2539716
- Ann Coloproctol.
- 2023 Feb;39(1):59-70.
- doi: 10.3393/ac.2021.01011.0144
Purpose: The standard treatment for locally advanced rectal cancer (LARC) is neoadjuvant chemoradiation (nCRT) followed by surgery. Several parameters are associated with patient survival in LARC. One of these parameters... -
- CITED
-
- Close
- SHARE
-
- Close
- The watch-and-wait strategy versus radical resection for rectal cancer patients with a good response (≤ycT2) after neoadjuvant chemoradiotherapy
-
Lee C, Park IJ, Lim SB, Yu CS, Kim JC
- KMID: 2536911
- Ann Surg Treat Res.
- 2022 Dec;103(6):350-359.
- doi: 10.4174/astr.2022.103.6.350
Purpose: This study aims to oncologic outcomes of the watch-and-wait (WW) strategy compared with radical resection (RR). Methods: Patients with rectal cancer who received neoadjuvant chemoradiotherapy (nCRT) and achieved ≤ycT2 between... -
- CITED
-
- Close
- SHARE
-
- Close
- Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay
-
Lee JH, Ryu JM, Ahn JH, Cho SY, Lee SK, Yu J, Chae BJ, Nam SJ, Han J, Lee JE, Kim SW
- KMID: 2537644
- J Breast Cancer.
- 2022 Dec;25(6):473-484.
- doi: 10.4048/jbc.2022.25.e49
Purpose: The GenesWell™ breast cancer test (BCT) is a recently developed multigene assay that predicts the risk of distant recurrence in patients with hormone receptor-positive (HR+) and human epidermal growth... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Value of Neutrophilto-Lymphocyte Ratio and Early Standardized Uptake Value Reduction in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy
-
Bae SJ, Ahn SG, Ji JH, Chu CH, Kim D, Lee J, Park S, Cha C, Jeong J
- KMID: 2537646
- J Breast Cancer.
- 2022 Dec;25(6):485-499.
- doi: 10.4048/jbc.2022.25.e44
Purpose: We investigated the treatment response and prognosis using the neutrophil-tolymphocyte ratio (NLR) and standardized uptake value (SUV) of 18F-fluorodeoxyglucose positron emission tomography ( 18F-FDG PET) in neoadjuvant settings. Methods: Baseline... -
- CITED
-
- Close
- SHARE
-
- Close
- Neoadjuvant therapy impact in early pancreatic cancer: “bioborderline” vs. “non-bioborderline”
-
Taboada AGM, Lominchar PL, Martínez MF, García-Alfonso P, Martin AM, Asencio JM
- KMID: 2536387
- Ann Hepatobiliary Pancreat Surg.
- 2022 Nov;26(4):363-374.
- doi: 10.14701/ahbps.22-023
Backgrounds/Aims: To analyze the results of the neoadjuvant treatment of patients in our center with early pancreatic cancer. Methods: Eighty-four patients with early pancreatic cancer (I–II) were included, of which 59... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database
-
Ueda A, Watari H, Mandai M, Fukuhara S, Sugitani Y, Ogino K, Kamijima S, Enomoto T
- KMID: 2537969
- J Gynecol Oncol.
- 2022 Nov;33(6):e78.
- doi: 10.3802/jgo.2022.33.e78
Objective To assess the incidence of bevacizumab-associated gastrointestinal (GI) perforation during first-line treatment of patients with ovarian, fallopian tube, or peritoneal cancer receiving neoadjuvant chemotherapy (NAC) in Japanese real-world clinical practice. Methods A... -
- CITED
-
- Close
- SHARE
-
- Close
- Update on Diagnosis and Treatment of Colorectal Cancer
-
Kim CW
- KMID: 2534746
- Ewha Med J.
- 2022 Oct;45(4):e8.
- doi: 10.12771/emj.2022.e8
The rate of colorectal cancer (CRC) has altered. Early-onset CRC patients are increasing, and it is one of the main causes of cancer-related death. Based on epidemiologic change, the CRC... -
- CITED
-
- Close
- SHARE
-
- Close
- Neoadjuvant Immunotherapy Following Definitive Surgical Treatment for Locoregionally Advanced Head and Neck Cancer: Perioperative Complication and Surgical Outcomes
-
Park JH, Park YM, Kim DH, Kim SH, Kim HR, Koh YW
- KMID: 2534450
- Korean J Otorhinolaryngol-Head Neck Surg.
- 2022 Oct;65(10):610-616.
- doi: 10.3342/kjorl-hns.2022.00283
Background and Objectives We analyzed surgical outcomes, perioperative complications, and mortality in head and neck squamous cell carcinoma (HNSCC) in patients who underwent curative surgery following neoadjuvant immunotherapy. Subjects and Method... -
- CITED
-
- Close
- SHARE
-
- Close
- Neoadjuvant chemoradiotherapy determines the prognostic impact of anastomotic leakage in advanced rectal cancer
-
Oh BY, Park YA, Huh JW, Cho YB, Yun SH, Kim HC, Lee WY
- KMID: 2534128
- Ann Surg Treat Res.
- 2022 Oct;103(4):235-243.
- doi: 10.4174/astr.2022.103.4.235
Purpose: The prognostic impact of anastomotic leakage (AL) in rectal cancer remains uncertain. We investigated the prognostic significance of AL in rectal cancer patients who underwent curative surgery, especially in... -
- CITED
-
- Close
- SHARE
-
- Close
- Genomic Correlates of Unfavorable Outcome in Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemoradiation
-
Wei Y, Wei C, Chen L, Liu N, Ou Q, Yin JC, Pang J, Fang Z, Wu X, Wang X, Mu D, Shao Y, Yu J, Yuan S
- KMID: 2534200
- Cancer Res Treat.
- 2022 Oct;54(4):1209-1218.
- doi: 10.4143/crt.2021.963
Purpose Neoadjuvant therapy modality can increase the operability rate and mitigate pathological risks in locally advanced cervical cancer, but treatment response varies widely. It remains unclear whether genetic alterations correlate with... -
- CITED
-
- Close
- SHARE
-
- Close
